The Netherlands Cancer Institute
Clinical trials sponsored by The Netherlands Cancer Institute, explained in plain language.
-
New Bladder-Sparing combo aims to avoid surgery in cancer patients
Disease control Not yet recruitingThis phase 2 trial tests whether a combination of two drugs—enfortumab vedotin (Padcev) and pembrolizumab (Keytruda)—can help people with muscle-invasive bladder cancer avoid bladder removal. About 56 participants will receive the drugs first, and those who respond well may get r…
Phase: PHASE2 • Sponsor: The Netherlands Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New hope for tough breast cancer: immune booster after chemo may keep cancer away
Disease control Not yet recruitingThis study tests whether adding the immunotherapy drug pembrolizumab to usual post-surgery treatment can help prevent breast cancer from returning in people with early-stage triple-negative breast cancer who still had cancer after initial chemo and pembrolizumab. About 1,000 adul…
Phase: PHASE3 • Sponsor: The Netherlands Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New imaging study aims to unlock HER2 secrets in lung cancer
Knowledge-focused Not yet recruitingThis study uses a special PET scan to track a tracer called 89Zr-trastuzumab in people with advanced lung cancer that has HER2 changes. The goal is to see if the tracer builds up differently in tumors with HER2 mutations versus those with too much HER2 protein. About 20 adults wi…
Phase: PHASE1 • Sponsor: The Netherlands Cancer Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC